-
Analyst Opinions
Agile IT – How Software-Defined Everything (SDx) Transforms Enterprise Fabric
Software-Defined Everything (SDx) Technology Overview Software-Defined Everything (SDx) is the key to managing enterprise IT infrastructure challenges. SDx technologies enable dynamic resource allocation, centralized management, security enhancement, agile provisioning, and integration with modern applications, fostering infrastructure efficiency and resilience. "Agile IT - How Software-Defined Everything (SDx) Transforms Enterprise Fabric" innovation radar report explores the pervasive influence of software-defined technologies across various sectors such as automotive, technology, telecom, aerospace & defense, manufacturing, energy & power, and consumer & retail. This report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Evexomostat in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Evexomostat in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Evexomostat in Solid Tumor Drug Details:Evexomostat (SDX-7320) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KP-1077 in Narcolepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KP-1077 in Narcolepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KP-1077 in Narcolepsy Drug Details: KP-1077 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KP-1077 in Idiopathic Hypersomnia (IH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KP-1077 in Idiopathic Hypersomnia (IH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KP-1077 in Idiopathic Hypersomnia (IH) Drug Details: KP-1077 is under development...
-
Product Insights
Sebou and Oulad N’Zala Field
Sebou and Oulad N'Zala Field is a producing field located in Rabat-Sale-Kenitra, Morocco. It is being operated by SDX Energy Morocco (Jersey) Ltd. Empower your strategies with our Sebou and Oulad N'Zala Field report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Company Profile
SDX Energy Plc – Company Profile
SDX Energy Plc (SDX) is an independent upstream company that carries out the exploration, development and production of crude oil, natural gas and natural gas liquids. The company operates oil and gas properties in Morocco and Egypt. Its portfolio of assets includes South Disouq Moulay Bouchta Ouest, South Disouq, West Gharib, Block-H Meseda, Sebou and Lalla Mimouna Concessions. The company also has operational interests in certain fields, including Mohsen, Shikabala prospects and El Deeb. The company has operational presence in...
Add to Basket -
Product Insights
NewSynDermix AG Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our SynDermix AG Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. SynDermix AG (SynDermix), formerly Pharmagenix AG, is a clinical-stage biotechnology company which develops bio-pharmaceutical products and medical devices for treating rare diseases, chronic wounds and ENT (ears, nose and throat) disorders. Its product portfolio includes SDX-3101 for treating chronic rhinosinusitis, SDX-3103 against migraine, SDX-3104 indicated for chronic wounds. The company's vibration therapies are based on connected medical devices that provide...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – KP-1077
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry KP-1077 Drug Details KP-1077 is under development for the treatment of idiopathic hypersomnia (IH)...
-
Product Insights
Drug Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms;...
-
Sector Analysis
MENA Oil and Gas 2022 – The outlook for oil, gas and petrochemicals projects in the Middle East and North Africa in 2022 – MEED Insights
The Middle East and North Africa (MENA) oil, gas, and petrochemicals projects outlook report is the latest premium intelligence report from MEED insight. Since 2010, around $414 billion of oil, gas & petrochemical project contracts have been awarded in the MENA region. The report provides a comprehensive snapshot of the regional oil and gas projects market at the start of 2020 and examines the outlook for policy and investment in oil, gas, and petrochemicals projects across the MENA region. The...